Benefit of azilsartan on blood pressure elevation around rest-to-active phase in spontaneously hypertensive rats

Kengo Isegawa, Yoshitaka Hirooka, Takuya Kishi, Keiji Yasukawa, Hideo Utsumi, Kenji Sunagawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Abnormal elevation of blood pressure in early morning (rest-to-active phase) is suggested to cause cardiovascular events. We investigated whether azilsartan (AZL), a novel potent angiotensin receptor blocker, suppresses blood pressure elevation from the light-rest to dark-active phase in spontaneously hypertensive rats (SHRs). AZL has a sustained depressor effect around the rest-to-active phase in SHRs to a greater extent than candesartan (CAN), despite their similar depressor effects for over 24 h. AZL did not cause sympathoexcitation. These results suggest that AZL has a more sustained depressor effect than CAN around the rest-to-active phase in SHRs, and might have advantages for early morning hypertension.

Original languageEnglish
Pages (from-to)45-50
Number of pages6
JournalClinical and Experimental Hypertension
Volume37
Issue number1
DOIs
Publication statusPublished - Feb 1 2015

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology

Fingerprint Dive into the research topics of 'Benefit of azilsartan on blood pressure elevation around rest-to-active phase in spontaneously hypertensive rats'. Together they form a unique fingerprint.

  • Cite this